Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We recently identified a novel cDNA encoding a retinoblastoma protein (pRb)-associated protein. It was named
RBP95
, which was composed of 838 amino acid residues with a calculated molecular size of 94,789 Da. Northern blot analysis showed a single mRNA of about 4. 5 kb ubiquitously expressed in human tissues. RH mapping results showed that
RBP95
is mapped to chromosome region 16p11.2-11.1. Sequence analysis indicated that
RBP95
contains a conserved pRb-binding motif LXCXE. Interaction between pRb and
RBP95
was confirmed in vivo and in vitro. This interaction requires the LXCXE motif of
RBP95
and the entire pocket region of pRb. Each point-mutant of the conserved amino acid residues in pRb-binding motif of
RBP95
would destroy its interaction with pRb.
RBP95
also contains a basic region leucine zipper and could homodimerize through its leucine zipper region.
RBP95
was located in the nucleus with a special pattern when expressed as a GFP fusion in HeLa cells. All these findings suggested that
RBP95
, a new member of pRb-associated protein, may function as a regulation factor in the process of
RNA polymerase II
-mediated transcription and/or transcriptional processing.
...
PMID:RBP95, a novel leucine zipper protein, binds to the retinoblastoma protein. 1094 55